A Functional Roadmap for Clinical Immunotherapy: Early Human Evidence of Recoverable T-Cell Dysfunction
Year: 2026
Type: preprint
Abstract: Many of the questions that now shape immunotherapy, including why chronically stimulated T cells fail and whether that failure can be reversed, were anticipated in functional studies of human disease decades before the relevant molecules were known. Between 1992 and 1996, studies of HIV infection and of an experimental model of allergic airway disease used functional assays to show that antigen- specific T-cell responses declined with disease stage and could be partly restored ex vivo by interleukin-2 (IL-2), and that allergen-specific Th2 memory was associated with eosinophilic inflammation and impaired lung function. The HIV studies foreshadowed, and described independently in humans, the loss of antigen-specific T-cell function now termed exhaustion, at around the time it was first described in mice. This Perspective places that work alongside the contributions that led to checkpoint blockade, adoptive cell therapy and anti-IL-5 biologics, and argues that a function-first approach remains a useful guide for adaptive immunotherapy.
Author: Bell, Stephen John Duncan
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7234091960
